News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|July 20, 2009

Italy: Towards Pharmaceutical Renaissance

Advertisement
External Link - article-612309.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Kim Plesnarski,  Syneos Health

Asembia's AXS26 Summit: Q&A with Kim Plesnarski

ByNicholas Jacobus,Kim Plesnarski
April 29th 2026
Stock.adobe.com Sale

Rocket Pharmaceuticals Enters $180 Definitive Agreement to Sell its Priority Review Voucher

ByNicholas Jacobus
April 29th 2026
Kim Plesnarski, vice president, strategic market access and patient support, Syneos Health

Asembia's AXS26 Summit: Are Regulatory Policies Impacting Early-Stage Portfolio Planning?

ByNicholas Jacobus,Kim Plesnarski
April 29th 2026
Stella Vnook

How are US Regulatory Actions Impacting Pricing?

ByMike Hollan,Dr. Stella Vnook
April 29th 2026
Jeff Golfman Send 123

Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?

ByNicholas Jacobus,Jeff Golfman
April 29th 2026
Advertisement
Advertisement

Trending on PharmExec

1

What Impact Could Recent US Regulatory Actions Have on Global Pricing and Launches?

2

Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry

3

Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon

4

Pharmaceutical Executive Daily: FDA Approves Breztri

5

Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us